CBD oil is everywhere and hard to ignore. In the UK alone, the CBD market is expected to grow to one billion pounds by 2025. The CBD oil is everywhere, whether it is good or bad, people are talking about it. CBD oil has a good number of sympathizers in the form of patients and parents of children with epilepsy. When Epidiolex, a CBD-based drug became legal in the United Kingdom and the United States, it was a winner for those who had been demanding legality for a long time. In many cases, seizures have fallen to zero, helping these patients lead normal lives as they deserve.
But while the hitherto pressing problem is dealt with if the CBD is as effective as what people claim, when another problem has opened its wings. Yes, the other problem, which is more and more pressing, is whether the bottle of CBD oil you just bought from the rack contains CBD or not!
This doubt arose when the Center for Medical Cannabis took samples in June in the UK and studied them for CBD content. None of the products studied contained CBD content despite their high costs. Although it is a side of the coin, the other side shows that the manufacturers also labeled the product containing acceptable levels of THC, while the product contained more toxic substance. THC is the psychoactive compound found in marijuana that causes addiction. CBD contains less than 0.03% THC, which makes it non-addictive.
Although the products do not contain an alarming level of THC, this indicates that the market is misleading its way to the banks. It seems that these real CBD companies are getting rid of illegal products in well-known markets. The question is why regulators do not do anything about it. The answer to this mystery is the lack of evidence or appropriate research helping people understand the compound. As it stands, it contains more than 400 micro-compounds that are difficult to study and, in addition to the evolution of laws, it has caused confusion. Subject matter experts in this field are not yet visible because the development of the CBD is still in its infancy.
CMC stated that it was not manufacturing errors, but that they could have been avoided if there were laboratory analysts. Harry Sumnall, professor of substance at a reputed university, also associates the problem with the lack of standard or repository defining manufacturing procedures and quality control. He also pointed out that there are many research organizations in the UK that could have addressed the issue, but lack of funding is taking them away.
The anti-inflammatory properties of CBD have made it a popular product. There is also the added benefit of not having a feeling of euphoria that causes people to change their minds. In just 3 years, the market has grown by 300 million pounds. The retail space is huge and the regulations can become extremely complicated. However, the UK also has certain rules and does not allow the sale of products based on medical benefits. In addition, if it is given for medical reasons, it must be supported by a Home Office license. But CMC also confirmed that rule # 2 was broken and was not followed to the letter. CMC believes that hype, Internet content and a large number of videos are primarily responsible for users' use of their mindset. Now, with several celebrities who also approve of it, the CBD is in the limelight.
Sumnall says that despite this negligence, no serious case has yet been reported. People benefit only by relieving cancer symptoms, relieving joint pain and injury, and also playing the role of antidepressant. He even points out that the WHO has also added that no serious causality has yet been reported because of the CBD. In the middle, the extremely unregulated US markets have reported vaping incidents, but no corroboration has yet been gathered.
Parveen Bhatarah, Regulatory Officer at CMC, has made it clear that she will develop standards that will be followed by all CMC members to address this issue. This will surely begin with a small attempt to regulate the giant market. Dragonfly CBD, which is a member of CMC, welcomes this decision and wants to participate in all conversations that can improve the market. They feel that incorrect labeling and not providing the promised content can lead to serious problems and it is best to smother it.
CMC now believes that with adequate funding, many independent agencies will be able to fund independent research and studies so that people are generally informed and do not take risks for their well-being.